Contact: Colleen T. White
Monique N. Dolecki
Franklin Lakes, NJ (October 29, 2012) – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it has received the WindMade™ label, a global consumer label for companies that use wind energy and other renewable energy sources. BD received the WindMade™ label for the Company’s global operations, and certifies that 35% of BD’s total electricity consumption is from wind power.
The label, which is backed by the UN Global Compact and conservation group WWF, requires participating companies to obtain at least 25% of their electricity from wind power.
Additionally, BD announced that it has ranked among the top 40 companies in Newsweek’s fourth annual “Green Rankings” of the 500 largest U.S. corporations based on environmental footprint, management of that footprint, and transparency. BD ranked 32nd overall and 4th in the Healthcare sector.
“I am very pleased that BD continues to receive external recognitions for our commitment to reducing our environmental footprint, while also providing tangible business benefits,” said Vincent A. Forlenza, BD Chairman, Chief Executive Officer and President. “I commend the many dedicated BD associates around the world who are driving this commitment forward as we strive toward our sustainability goals.”
WindMade™ is the first global consumer label identifying organizations and products that use wind power in their operations or production. For more, please visit www.windmade.org. To view the full Newsweek Green Rankings, please visit www.newsweek.com/green.
To learn more about BD’s commitment to environmental stewardship, and to access BD’s 2011 Sustainability Report, please visit www.bd.com/sustainability.
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.